World Congress and Expo on Cardio Health, March 2-4, 2021 Hanoi, Vietnam
*Corresponding Author:
Copyright: © 2021 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
The global Cardiovascular Drugs Market was valued approximately US$ 80.0 Bn in 2016 and is anticipated to register CAGR of over 1.0% from 2017 to 2025 to reach value of approximately US$ 91.0 Bn by 2025. Drug classes used to treat cardiovascular indications such as hyperlipidaemia, hypertension are likely to fuel expansion of the global cardiovascular drugs market from 2017 to 2025.
